Sprint Bioscience is a pharmaceutical company focused on developing drugs to fight cancer. It runs pharmaceutical projects from conception to drug candidates ready for clinical trials. Sprint Bioscience's portfolio of projects is focused on exploiting metabolic pathways for the treatment of cancer. Additionally, the company develops a program for type 2 diabetes.
Market capitalization (17-Sept-2021)
Closing stock price (17-Sept-2021)
Sprint Bioscience has 97 Twitter Followers. The number of followers has increased 4.3% month over month and increased 9.1% quarter over quarter
When was Sprint Bioscience founded?
Sprint Bioscience was founded in 2009.
Who are Sprint Bioscience key executives?
Sprint Bioscience's key executives are Rune Nordlander, Jessica Martinsson and Erik Kinnman.
How many employees does Sprint Bioscience have?
Sprint Bioscience has 33 employees.
Who are Sprint Bioscience competitors?
Competitors of Sprint Bioscience include Italfarmaco, Ascentage Pharma and Janssen Pharmaceuticals.
Receive alerts for 300+ data fields across thousands of companies